Date: 2013-02-12
Type of information: Collaboration agreement
Compound: companion diagnostics
Company: Dako (Denmark) Pfizer (USA - NY)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On February 12, 2013, Dako, an Agilent Technologies company, has announced it has entered into a collaboration agreement with Pfizer in the field of companion diagnostics. The agreement constitutes a legal framework for various collaboration projects between the two companies, covering research, development and commercialization as well as advisory services.
Financial terms: Financial terms of the agreement were not disclosed.
Latest news:
